BNTC
Benitec Biopharma Ltd ADRNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$384.43M
P/E Ratio
—
EPS
$-0.93
Beta
0.28
52W High
$17.10
52W Low
$9.85
50-Day MA
$11.75
200-Day MA
$12.60
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About Benitec Biopharma Ltd ADR
Benitec Biopharma Inc., a developing biotechnology company, is focused on the development of new genetic drugs. The company is headquartered in Hayward, California.
Fundamentals
| Revenue (TTM) | 7,000 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-46.54M |
| Operating Margin | 0.00% |
| Return on Equity | -29.60% |
| Return on Assets | -19.90% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $5.34 |
| Price-to-Book | 2.07 |
| Price-to-Sales (TTM) | 2770.13 |
| EV/Revenue | 10457.68 |
| EV/EBITDA | 850.87 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 12.50% |
| Shares Outstanding | $34.35M |
| Float | $17.87M |
| % Insiders | 2.70% |
| % Institutions | 98.25% |
Historical Volatility
HV 10-Day
69.50%
HV 20-Day
56.04%
HV 30-Day
48.93%
HV 60-Day
51.97%
HV Rank
25.4%
Volatility is currently expanding
Analyst Ratings
Consensus ($25.80 target)
1
Strong Buy6
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026